Leerink Swann Reiterates an 'Outperform' on Cadence Pharma (CADX); View on Ofirmev Markman Hearing and Upcoming Decisions
Tweet Send to a Friend
Leerink Swann reiterates an 'Outperform' on Cadence Pharma (NASDAQ: CADX) price target of $5.00.
Analyst, Michael Schmidt, said, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Michael Schmidt, said, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
